According to GuruFocus list of 52-week highs, these guru stocks have reached their 52-Week Highs.
Coca-Cola European Partners PLC (CCE, Financial) reached the 52-week high of $46.13
Coca-Cola European Partners PLC is a soft drinks manufacturer. It produces and markets non-alcoholic beverages in the European region. Coca-Cola European Partners PLC sells nonalcoholic beverage products in Europe. The company purchases concentrates and syrups from other beverage manufacturers under a license, then produces, packages and distributes the beverages to retailers.
The price of Coca-Cola European Partners PLC shares has reached $46.13, which is 0.1% off the 52-week high of $46.16. Coca-Cola European Partners PLC has a market cap of $22.14 billion; its shares were traded around $46.13 with a price-earnings ratio of 28.86 and price-sales ratio of 1.61. The trailing 12-month dividend yield of Coca-Cola European Partners PLC stocks is 2.55%. The forward dividend yield of Coca-Cola European Partners Plc stocks is 2.80%.
Coca-Cola European Partners PLC recently announced its interim results for the third quarter ended Sept. 28 and maintained its full-year 2018 outlook. Highlights include:
- Nine-month diluted earnings per share were €1.58 on a reported basis or €1.76 on a comparable basis, including a negligible impact from currency translation.
- Nine-month revenue totalled €8.7 billion, up 4%, or up 4.5% on a comparable and foreign currency-neutral basis. Volume decreased 0.5% on a comparable basis, partly reflecting the impact of recent strategic portfolio and pricing decisions.
- Nine-month reported operating profit was €1.1 billion, up 4%; comparable operating profit was €1.2 billion, up 7.5% on a comparable basis, or up 8% on a comparable and fx-neutral basis.
- Third-quarter diluted earnings per share were 73 euro cents on a reported basis or 76 euro cents on a comparable basis, including a negligible impact from currency translation.
Merck & Co Inc. (MRK, Financial) reached the 52-week high of $73.32
Merck & Co Inc. is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer and infections. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. From a geographical perspective, close to half of the company's sales are generated in the U.S.
The price of Merck & Co Inc. shares has reached $73.32, which is 1.6% off the 52-week high of $74.49. Merck & Co. Inc. has a market cap of $195 billion; its shares were traded around $73.32 with a price-earnings ratio of 146.64 and price-sales ratio of 4.84. The trailing 12-month dividend yield of Merck & Co. Inc. stocks is 2.63%. The forward dividend yield of Merck & Co. Inc. stocks is 3.04%.
Merck recently announced financial results for the third quarter of 2018. Highlights include:
- Sales were $10.8 billion.
- Earnings per share were 73 cents.
- Full-year revenue range narrowed to between $42.1 billion and $42.7 billion, including a minimal impact from foreign exchange.
Executive Vice President and President Global Human Health Adam H. Schechter sold 277,879 shares of Merck & Co. stock on Nov. 1 at the price of $73.81 per share. The price of the stock has decreased by 0.66% since.
Hormel Foods Corp. (HRL, Financial) reached the 52-week high of $44.22
Hormel Foods Corp. is engaged in manufacturing and sale of variety of food products primarily, pork and turkey and the marketing of those products throughout the U.S. and internationally. Hormel manufactures, sells and distributes a variety of food products, primarily pork and turkey.Â
The price of Hormel Foods Corp. shares has reached $44.22, which is 0.5% off the 52-week high of $43.98. Hormel Foods Corp. has a market cap of $23.57 billion; its shares were traded around $44.22 with a price-eanrings ratio of 24.70 and price-sales ratio of 2.51. The trailing 12-month dividend yield of Hormel Foods Corp. stocks is 1.71%. The forward dividend yield of Hormel Foods Corp. stocks is 1.74%. Hormel Foods Corp. had an annual average earnings growth of 9.50% over the past 10 years. GuruFocus rated Hormel Foods Corp. the business predictability rank of 4-star.
Hormel Foods Corp. recently reported results for the third quarter of fiscal 2018. Highlights include:
- Record diluted earnings per share of 39 cents, up 15% from 2017 earnings per share of 34 cents.
- Fiscal 2018 earnings guidance reaffirmed at $1.81 to $1.95 per share.
- Record net sales of $2.4 billion, up 7%; organic net sales flat.
- Volume of 1.2 billion pounds, up 5%; organic volume up 1%.
- Operating margin of 11.1% compared to 12.7% last year.
- Effective tax rate of 18.4% compared to 34.3% last year.
- Year-to-date cash flow from operations of $743 million, up 40% compared to last year.
Nordstrom Inc. (JWN, Financial) reached the 52-week high of $67.35
Nordstrom Inc. operates as a fashion specialty retailer in the U.S. It sells its products through various channels, including Nordstrom full-line stores, Nordstrom Rack off-price stores, Last Chance clearance stores and Jeffrey boutiques. Nordstrom is a retailer of women's apparel (31% of sales), shoes (23%), men's apparel (17%), accessories (12%), cosmetics (11%) and kids' apparel (3%) catering to the upper-middle and high-end income classes. Nordstrom operates more than 350 stores, including full-priced Nordstrom and Nordstrom Rack stores. Additionally, customers are served online through Nordstrom.com, Nordstromrack.com, HauteLook and Trunk Club.
The price of Nordstrom Inc. shares has reached $67.35, which is 0.5% off the 52-week high of $67.70. Nordstrom Inc. has a market cap of $11.35 billion; its shares were traded around $67.35 with a price-earnings ratio of 22.30 and price-sales ratio of 0.71. The trailing 12-month dividend yield of Nordstrom Inc. stocks is 2.20%. The forward dividend yield of Nordstrom Inc. stocks is 2.23%. Nordstrom Inc. had an annual average earnings growth of 7.60% over the past 10 years. GuruFocus rated Nordstrom Inc. the business predictability rank of 2-star.
Nordstrom Inc. recently reported earnings per diluted share for the second quarter ended Aug. 4, 2018 of 95 cents, which exceeded company expectations, reflecting top-line growth across its Full-Price and Off-Price businesses. Based on first-half results, the company raised its full-year earnings per diluted share expectations to $3.50 to $3.65 from its prior outlook of $3.35 to $3.55. Total company net sales increased 7.1% for the second quarter . Second quarter net earnings were $162 million compared with $110 million.
Senior Vice President and Secretary Robert Sari sold 8,795 shares of Nordstrom stock on Oct, 10 at the price of $62.50 per share. The price of the stock has increased by 7.76% since.
Lamb Weston Holdings Inc. (LW, Financial) reached the 52-week high of $78.63
Lamb Weston Holdings Inc. is a producer, provider and marketer of value-added frozen potato products. It is a supplier of frozen potato products internationally. Its products include puff, chips, steak cut fries, trim fries and appetizers, among others. Lamb Weston Holdings Inc. is a producer, distributor and marketer of value-added frozen potato products. It is engaged in four reportable segments: Global, Foodservice, Retail and Other.Â
The price of Lamb Weston Holdings Inc. shares has reached $78.63, which is 1.7% off the 52-week high of $79.97. Lamb Weston Holdings Inc. has a market cap of $11.52 billion; its shares were traded around $78.63 with a price-earnings ratio of 26.31 and price-sales ratio of 3.28. The trailing 12-month dividend yield of Lamb Weston Holdings Inc. stocks is 0.98%. The forward dividend yield of Lamb Weston Holdings Inc. stocks is 0.99%.
Lamb Weston Holdings Inc. announced recently its fiscal first quarter 2019 results. Net sales were $914.9 million, up 12% versus the year-ago period. Income from operations rose 11% to $152.6 million from the prior-year period. Adjusted Ebitda including unconsolidated joint ventures was $212.9 million, up 11%, primarily due to growth in income from operations. Diluted earnings per share increased 17 cents, or 30%, to 73 cents, while adjusted diluted earnings per share increased 16 cents, or 28%, to 73 cents.
Note: I do not own the stocks discussed.
